analyzeportfolio
Nasdaq · Financials

Oaktree Specialty Lending Corp (OCSL)

As-reported financials and SEC filings for Oaktree Specialty Lending Corp. The latest annual period is FY2025. The latest reported quarter is Q3 FY2026. Financial statements come straight from the company’s EDGAR filings; valuation figures such as P/E and market cap use market data.

About Oaktree Specialty Lending Corp

Oaktree Specialty Lending Corp is a specialty finance company that provides customized credit solutions to middle-market companies with limited access to public or syndicated capital markets. It offers various financing options including first and second lien loans, unsecured and mezzanine loans, bonds, preferred equity, and equity co-investments. The company primarily serves companies with enterprise values between $100 million and $750 million and manages a portfolio focused on debt investments in resilient businesses.

Snapshot

Revenue
Revenue growth (YoY)
Net income
$33.9M
Diluted EPS
$0.39
Gross margin
Operating margin
Net margin
FCF margin
ROE
2.3%
net income / fiscal-year-end equity
P/E
27.2×
trailing when available, otherwise FY EPS
Market cap
$1.15B
Long-term debt / equity
1.01×
non-current term debt only

Fundamentals are from SEC filings for FY2025, the latest annual period (ended September 30, 2025). P/E and market cap are derived from stored market prices, last retrieved on a rolling basis and typically within the past week.

What changed at Oaktree Specialty Lending

  • Net income fell 41.4% to $34M in FY2025.

Computed from the as-reported figures in the statements below. A change we cannot state from filed figures is left out rather than estimated.

Peer comparison

Where Oaktree Specialty Lending’s fundamentals sit among the 51 business development companies. Each figure is ranked only against peers that report it, from lowest (left) to highest (right).

ROE2.3%
28th percentile of 48
P/E27.2×
89th percentile of 38
Long-term debt / equity1.01×
19th percentile of 33
Short interest4.43d
56th percentile of 49

Oaktree Specialty Lending’s P/E of 27.2 ranks in the 89th percentile of the 38 peers with a meaningful P/E.

1 reported insider purchase (code P) totaling $21,581 in the last 90 days. For context, about 14% of companies in the universe saw any reported insider purchase (code P) in the same window. Browse insider activity →

Percentiles describe where a figure sits among business development company peers reporting it (100th = highest). They are position within a peer group, not a rating, and not investment advice. Short interest ranking uses days to cover from FINRA Consolidated Short Interest data; FINRA is the owner and source of that data, included at no additional charge.

Institutional ownership

Held by 3 quant / multi-strat books among the superinvestors we track; no conviction manager currently reports a position.

Conviction investors
0
+3 quant / multi-strat
Initiated / added
1
0 new, 1 added
Reduced / exited
4
2 trimmed, 2 exited
Combined position
$7.0M
reported long value
InvestorAs ofPosition valueSharesChange
Two Sigma InvestmentsquantQ2 2026$4.1M340.3KReduced
Citadel AdvisorsquantQ2 2026$1.9M155.9KReduced
AQR Capital ManagementquantQ2 2026$1.0M87.4KAdded

No longer held by: D. E. Shaw (as of Q2 2026), Millennium Management (as of Q2 2026)

From quarterly Form 13F filings, which can be up to 45 days delayed. Long US-listed positions only: excludes short positions, options, cash, bonds, and non-US holdings, so this is not a manager’s complete portfolio. Counts are of the investors we track, not all institutions. Not investment advice.

Recent insider activity

Non-derivative buys and sells (codes P/S) reported by officers, directors and 10% owners on SEC Form 4.

Buys (90d)
1
1 insider
Bought (90d)
$22K
code P value
Sells (90d)
0
Reported activity
Net buying
by $ value, 90d
Trade dateInsiderTypeSharesPriceValue
2026-08-12
filed 2026-08-13
Panossian ArmenSee RemarksBuy1.7K$12.69$22K

Reported non-derivative purchases and sales (codes P/S) — which may be open-market or private; excludes option exercises, grants, and shares withheld for taxes. Dates shown are the trade date; a Form 4 can be filed days to years later. A sale can be routine (e.g. a pre-set 10b5-1 plan), so read individual transactions in context. From SEC Form 4. Not investment advice.

Short interest

Total shares sold short as of each twice-monthly FINRA settlement. Rising short interest means more investors are positioned against the stock; days to cover estimates how many trading days of average volume that position represents.

Shares short
3.0M
settled 2026-08-14
Change vs prior
-5.6%
vs previous settlement
Days to cover
4.43
at avg daily volume
Avg daily volume
682.5K
FINRA reported
SettlementShares shortChangeDays to cover
2026-08-143.0M-5.6%4.43
2026-07-313.2M-12.7%7.05
2026-07-153.7M+1.4%8.69

Source: FINRA Consolidated Short Interest. FINRA is the owner and source of the FINRA-supplied data, which is included at no additional charge for your own personal or professional use; republishing or redistributing it is not permitted. Settlement dates are shown; FINRA publishes each settlement about nine business days later, so the latest figure can be two to four weeks old. Not presented as a percentage of float. No FINRA endorsement of this product is implied. Not investment advice.

Income statement (as reported)

 FY2025FY2024FY2023FY2022FY2021
Revenue
Gross profit
Operating income
Net income$33.9M$57.9M$117.3M$29.2M$237.3M
Diluted EPS$0.39$0.72$1.63$0.48$4.39

Figures as reported to the SEC. Underlined values link to the filing they came from; dotted values are calculated by us from reported figures; “adj” means restated for a stock split (hover to see the figure as filed). Full details: where the numbers come from.

Balance sheet (as reported)

 FY2025FY2024FY2023FY2022FY2021
Cash and equivalents$79.6M$64.0M$136.4M$23.5M$29.3M
Current assets
Total assets$3.00B$3.20B$3.22B$2.65B
Current liabilities
Long-term debt$1.49B$1.64B$1.60B$1.30B
Total liabilities$1.54B$1.71B$1.70B$1.40B
Total equity$1.47B$1.49B$1.52B$1.25B$1.31B

Figures as reported to the SEC. Underlined values link to the filing they came from; dotted values are calculated by us from reported figures; “adj” means restated for a stock split (hover to see the figure as filed). Full details: where the numbers come from.

Cash flow (as reported)

 FY2025FY2024FY2023FY2022FY2021
Operating cash flow$228.4M$19.1M$228.8M$22.4M$-230.5M
Capital expenditure
Free cash flow

Figures as reported to the SEC. Underlined values link to the filing they came from; dotted values are calculated by us from reported figures; “adj” means restated for a stock split (hover to see the figure as filed). Full details: where the numbers come from.

Quarterly trend (as reported)

QuarterRevenueRevenue YoYNet incomeDiluted EPS
Q3 FY2026$30.9M$0.35
Q2 FY2026$-18.9M$-0.21
Q1 FY2026$5.6M$0.06
Q4 FY2025$24.6M$0.28
Q3 FY2025$38.4M$0.44
Q2 FY2025$-36.2M$-0.42
Q1 FY2025$7.2M$0.09
Q4 FY2024$36.9M$0.45

Latest 8 reported quarters, from company XBRL filings on SEC EDGAR.

Company facts

ExchangeNasdaq
SectorFinancials
Latest annual periodFY2025 (ended September 30, 2025)
Latest reported quarterQ3 FY2026 (ended June 30, 2026)
Oldest indexed filing2010
SEC CIK1414932

Selected SEC filings

10-K2025-11-18
View on EDGAR →
10-Q2026-08-05
View on EDGAR →
10-Q2026-05-05
View on EDGAR →
10-Q2026-02-04
View on EDGAR →
10-Q2025-08-05
View on EDGAR →
8-K2026-08-05
View on EDGAR →
8-K2026-05-05
View on EDGAR →
8-K2026-03-04
View on EDGAR →

Largest Financials peers

All Financials companies →

Monitor OCSL

Get an alert when Oaktree Specialty Lending files something material, see which superinvestors own it, and ask its filings a question with cited answers.

Monitor OCSL free

Includes one free filing-grounded research answer. Or check your whole portfolio, no account needed.

Data sourced from SEC EDGAR. Figures are as-reported and may be unaudited or restated; verify against the source filing before relying on them. Informational only. Not investment advice.